Barely two weeks after the pricing and profit margins of Big Pharma’s swine flu vaccines and anti-virals were the subject of the critical spotlight in the UK media, Roche’s Tamiflu (oseltamivir) has come under scrutiny, fuelled by articles in the British Medical Journal (BMJ) and The Lancet Infectious Diseases questioning the drug’s effectiveness in young [...]
PharmExec Blog
Follow Us
RSS
Bookstore
UK: Swine Flu ‘Backlash’ Continues